Janux Therapeutics (JANX) Shares Issued (2020 - 2026)

Janux Therapeutics (JANX) has 6 years of Shares Issued data on file, last reported at $3.5 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $3.5 million, up 293.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (up 85.67% YoY), and the FY2021 annual result was $204.2 million, changed N/A from the prior year.
• Shares Issued advanced to $3.5 million in Q1 2026 per JANX's latest filing, from $901000.0 in the prior quarter.
• Over five years, Shares Issued peaked at $3.5 million in Q1 2026 and troughed at $901000.0 in Q1 2025.
• A 4-year average of $1.9 million and a median of $1.6 million in 2023 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2025 and 2026: Shares Issued slumped 45.62% in 2025, then jumped 293.45% in 2026.
• A 4-year view of Shares Issued shows it stood at $1.6 million in 2023, then increased by 4.87% to $1.7 million in 2024, then tumbled by 45.62% to $901000.0 in 2025, then jumped by 293.45% to $3.5 million in 2026.
• Business Quant data shows JANX's Shares Issued at $3.5 million in Q1 2026, $901000.0 in Q1 2025, and $1.7 million in Q1 2024.